Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum β lactamase

Acta Urologica Japonica

Volumn 53, Issue 11, 2007, Pages 777-782

  Hori, Junichi ^a   Yamaguchi, Satoshi ^a   Osanai, Hiroaki ^a   Kinebuchi, Takahiro ^a   Usami, Kazuo ^a   Takahashi, Naoshi ^b   Ishii, Yoshikazu ^b  

^a Hokkaido Social Welfare Association Furano Hospital   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

E. coli; ESBL; Multi drug resistance bacteria; Nosocomial infection; UTI

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

AGED; ARTICLE; BIOSYNTHESIS; BLADDER CATHETERIZATION; CROSS INFECTION; CYSTITIS; DRUG EFFECT; ENTEROBACTER INFECTION; ENZYMOLOGY; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; NEUROGENIC BLADDER; PYELONEPHRITIS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; CYSTITIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PYELONEPHRITIS; URINARY BLADDER, NEUROGENIC; URINARY CATHETERIZATION;

EID: 37349071493     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Japanese source
2. Japanese source
3. Colodner R, Reznik B, Gal B, et al.: Evaluation of a novel kit for the rapid detection of extended-spectrum β-lactamases. Eur J Clin Microbiol Infect Dis 25 : 49-51, 2006
4. Japanese source
5. ESBL. Idsc.Tokyo-eiken.go.jp/epid/2005/ tbkj 2610.html
6. Japanese source
7. Japanese source
8. David LP: Resistance in Gram-Negative Bacteria : enterobactericeae. Am J Med 119 : 520-528, 2006
9. Japanese source
10. Muratani T and Matsumoto T: Urinary tract infection caused by fluoroquinolone and cephem resistant enterobacteriaceae. Int J Antimicrobial Agents 285 : S10-S13, 2006
11. Esther C, Veronica R, Mariona X, et al.: Risk factors for community-onset urinary tract infections due to Escherichia coli harboring extended-spectrum β-lactamases. J Antimicrob Chemother 57 : 780-783, 2006
12. Pena C, Gudiol C, Saballs M, et al.: Risk factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalized patients. Clin Microbiol Infect 12 : 279-284, 2006
13. Sujata MB, Paul GA, William AC, et al.: Outcomes evaluation of patients with ESBL and non-ESBL producing Escherichia coli and Klebsiella species as defined by CLSI reference methods : report from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis 54 : 231-236, 2006
14. Wong ES and Hooton TM: Guideline for prevention of catheter-associated urinary tract infections. Am J Infect Control 11 : 28-36, 1983
15. Japanese source